SlideShare ist ein Scribd-Unternehmen logo
1 von 17
Pharmaceutical and
Formulation Considerations
What is Pharmaceutical
technology?
• Pharmaceutical Technology is the discipline of
pharmacy that deals with the process of turning a
new chemical entity (NCE) into a medication to be used
safely and effectively by patients.
• It is also called the science of dosage form design.
• It deals with the formulation of a pure drug substance
into a dosage form
Drug and medicine
• Medicine is actually the drug delivery system
• That is, they are means of introducing drugs to the body
in safe, efficacious, reproducible and convenient ways
• Medicines are rarely drugs alone, but requires excipients
or additives or pharmaceutical ingredients to be
formulated into dosage forms
Different Dosage Forms
Pharmaceutical ingredients or excipients
• The non-medicinal agents that are given as parts of a
formulation in combination with a drug substance to
produce a final dosage form and serve varied and
specialized pharmaceutical functions are known as
pharmaceutical ingredients or excipients.
• Examples:
For solutions- solvents, flavors, sweeteners, colorants,
preservatives, stabilizers etc.
For tablets- diluents or fillers, binders, lubricants,
disintegrating agents etc.
What are the purposes of formulating
different types of dosage forms?
• In order to provide the safe and appropriate dose of a
drug to the patient, drug substances are formulated in a
dosage forms
• Selective use of different excipients produces dosage
forms of various types
• Besides providing the safe and convenient delivery of
accurate dosage, there are different purposes for which
different dosage forms are designed.
These are :
1) To protect the drug substance from the destructive
influences of atmospheric oxygen or humidity (coated
tablets, sealed ampuls)
Sealed ampoules and coated
tablets
The purposes …
2) To protect the drug substance from the destructive
influences of gastric acid after oral administration
( enteric coated tablets)
The purposes …
3) To conceal the bitter, salty or offensive taste or odor of
a drug substance (capsules, coated tablets, flavored
syrups)
4) To provide liquid preparations of substances that are
either insoluble or unstable in the desired vehicle
( suspensions)
The purposes …
5) To provide clear liquid dosage forms of substances
( syrups, solution)
6) To provide rate-controlled drug action ( various
controlled release tablets, capsules and suspensions)
7) To

provide optimal drug action from topical administration
sites ( ointments, creams, transdermal patches and
ophthalmic ear & nasal preparations)
The purposes …
8) To provide for insertion of a drug into one of body’s
orifices ( rectal or vaginal suppositories)
The purposes …
9) To provide for placement of drugs directly in the
bloodstream or body tissues (injections)

10) To provide for optimal drug action through inhalation
therapy ( inhalants and inhalation aerosols)
Major considerations in dosage form design
• Three major things should be considered before
designing a dosage form :
-The physicochemical considerations
- The biochemical considerations
- Determination of the desired product type and
establishment of a framework for product development
Major considerations ….
• Then, various initial formulations of the product are
developed and examined for desired features (e.g., drug
release profile, bioavailability, clinical effectiveness etc.)
• The formulation that best meets the goals for the product
is selected as “master formula”.
Major considerations ….
• Then a pilot batch and subsequently large scale
production is carried on
• Each of the subsequently prepared batch of the product
must meet the specifications established in the master
formula
• Most commonly a manufacturer prepares a drug
substance in several dosage forms and strengths for the
efficacious and convenient treatment of disease
Major considerations….
• Some therapeutic matters are also considered before
formulating different kinds of dosage forms like- nature of illness ( whether emergency or not)
- manner of treatment ( whether local or systemic action)
- the age and anticipated condition of the patient ( for
infants and children liquid preparation is preferred, for
young patient with cough & vomiting injections or
suppositories are preferred)
Major considerations….
- in case of swallowing problem, chewable tablet or
capsules may be prepared
-

to reduce the frequency of administration, sustained
release or extended released form is preferred

- Thus the therapeutic considerations, in turn helps to
decide the suitable dosage form, the appropriate route of
administration, suitable duration and dose frequency if
the drug in question

Weitere ähnliche Inhalte

Was ist angesagt?

Was ist angesagt? (20)

Excipients
ExcipientsExcipients
Excipients
 
Introduction to dosage form
Introduction to dosage formIntroduction to dosage form
Introduction to dosage form
 
Pharmaceutical excipients
Pharmaceutical excipients Pharmaceutical excipients
Pharmaceutical excipients
 
Importance of partition coefficient, solubility and dissociation on pre-formu...
Importance of partition coefficient, solubility and dissociation on pre-formu...Importance of partition coefficient, solubility and dissociation on pre-formu...
Importance of partition coefficient, solubility and dissociation on pre-formu...
 
Solid Dosage Forms
Solid Dosage FormsSolid Dosage Forms
Solid Dosage Forms
 
suspensions
 suspensions suspensions
suspensions
 
Tablets
TabletsTablets
Tablets
 
Preformulation
PreformulationPreformulation
Preformulation
 
Solid dosage forms (capsules)
Solid dosage forms (capsules)Solid dosage forms (capsules)
Solid dosage forms (capsules)
 
Parentrals
ParentralsParentrals
Parentrals
 
Preformulation studies
Preformulation studiesPreformulation studies
Preformulation studies
 
Parenterals
ParenteralsParenterals
Parenterals
 
Formulation and development of parenterals
Formulation and development of parenteralsFormulation and development of parenterals
Formulation and development of parenterals
 
Powder - pharmaceutics
Powder - pharmaceuticsPowder - pharmaceutics
Powder - pharmaceutics
 
Preformulation
PreformulationPreformulation
Preformulation
 
Tablets
TabletsTablets
Tablets
 
Powders
PowdersPowders
Powders
 
Heckel Plots for Tablet Compression
Heckel Plots for Tablet CompressionHeckel Plots for Tablet Compression
Heckel Plots for Tablet Compression
 
Pharmaceutical Technology 1
Pharmaceutical Technology 1Pharmaceutical Technology 1
Pharmaceutical Technology 1
 
Tablet manufacturing process
Tablet manufacturing processTablet manufacturing process
Tablet manufacturing process
 

Ähnlich wie Dosage form design

PharmaceuticaI_Dosage_forms_1661621157.pdf
PharmaceuticaI_Dosage_forms_1661621157.pdfPharmaceuticaI_Dosage_forms_1661621157.pdf
PharmaceuticaI_Dosage_forms_1661621157.pdf
SamranKhanSuri
 

Ähnlich wie Dosage form design (20)

PHARMACEUTICS.pptx
PHARMACEUTICS.pptxPHARMACEUTICS.pptx
PHARMACEUTICS.pptx
 
clinical pharmacokinetics
clinical pharmacokineticsclinical pharmacokinetics
clinical pharmacokinetics
 
01._INTRODUCTION_TO_Pharmaceutical_technology_2017.pdf
01._INTRODUCTION_TO_Pharmaceutical_technology_2017.pdf01._INTRODUCTION_TO_Pharmaceutical_technology_2017.pdf
01._INTRODUCTION_TO_Pharmaceutical_technology_2017.pdf
 
BLT pharmacokinetics.pptx
BLT pharmacokinetics.pptxBLT pharmacokinetics.pptx
BLT pharmacokinetics.pptx
 
pharmaceutics dosage form design chapt-4
 pharmaceutics dosage form design chapt-4  pharmaceutics dosage form design chapt-4
pharmaceutics dosage form design chapt-4
 
Introduction.pdf
Introduction.pdfIntroduction.pdf
Introduction.pdf
 
Dosage Form
Dosage FormDosage Form
Dosage Form
 
Solid.pptx
Solid.pptxSolid.pptx
Solid.pptx
 
introduction.pptx
introduction.pptxintroduction.pptx
introduction.pptx
 
NeedDFs.pptx
NeedDFs.pptxNeedDFs.pptx
NeedDFs.pptx
 
MODIFIED RELEASE DRUG DELIVERY SYSTEM
MODIFIED RELEASE DRUG DELIVERY SYSTEMMODIFIED RELEASE DRUG DELIVERY SYSTEM
MODIFIED RELEASE DRUG DELIVERY SYSTEM
 
DOSAGE FORMS
DOSAGE FORMSDOSAGE FORMS
DOSAGE FORMS
 
4_2019_03_10!11_08_20_PM.pptx
4_2019_03_10!11_08_20_PM.pptx4_2019_03_10!11_08_20_PM.pptx
4_2019_03_10!11_08_20_PM.pptx
 
PCT122 LECTURE 2 2023.pptx
PCT122 LECTURE 2 2023.pptxPCT122 LECTURE 2 2023.pptx
PCT122 LECTURE 2 2023.pptx
 
Unit 1(g. ph) -n
Unit 1(g. ph) -nUnit 1(g. ph) -n
Unit 1(g. ph) -n
 
PharmaceuticaI_Dosage_forms_1661621157.pdf
PharmaceuticaI_Dosage_forms_1661621157.pdfPharmaceuticaI_Dosage_forms_1661621157.pdf
PharmaceuticaI_Dosage_forms_1661621157.pdf
 
Pharmaceutics Unit -1.pptx
Pharmaceutics Unit -1.pptxPharmaceutics Unit -1.pptx
Pharmaceutics Unit -1.pptx
 
Tablet manufacturing tech
Tablet manufacturing techTablet manufacturing tech
Tablet manufacturing tech
 
medication administration.pptx
medication administration.pptxmedication administration.pptx
medication administration.pptx
 
school practice_240130_141325.PDF
school practice_240130_141325.PDFschool practice_240130_141325.PDF
school practice_240130_141325.PDF
 

Kürzlich hochgeladen

1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
QucHHunhnh
 
Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdf
Chris Hunter
 
The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptx
heathfieldcps1
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
QucHHunhnh
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
PECB
 

Kürzlich hochgeladen (20)

How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17
 
Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptx
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.ppt
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and Mode
 
Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdf
 
The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptx
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
psychiatric nursing HISTORY COLLECTION .docx
psychiatric  nursing HISTORY  COLLECTION  .docxpsychiatric  nursing HISTORY  COLLECTION  .docx
psychiatric nursing HISTORY COLLECTION .docx
 
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
 
ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot Graph
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
 
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
 
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17  How to Extend Models Using Mixin ClassesMixin Classes in Odoo 17  How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
 
Asian American Pacific Islander Month DDSD 2024.pptx
Asian American Pacific Islander Month DDSD 2024.pptxAsian American Pacific Islander Month DDSD 2024.pptx
Asian American Pacific Islander Month DDSD 2024.pptx
 
Micro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfMicro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdf
 

Dosage form design

  • 2. What is Pharmaceutical technology? • Pharmaceutical Technology is the discipline of pharmacy that deals with the process of turning a new chemical entity (NCE) into a medication to be used safely and effectively by patients. • It is also called the science of dosage form design. • It deals with the formulation of a pure drug substance into a dosage form
  • 3. Drug and medicine • Medicine is actually the drug delivery system • That is, they are means of introducing drugs to the body in safe, efficacious, reproducible and convenient ways • Medicines are rarely drugs alone, but requires excipients or additives or pharmaceutical ingredients to be formulated into dosage forms
  • 5. Pharmaceutical ingredients or excipients • The non-medicinal agents that are given as parts of a formulation in combination with a drug substance to produce a final dosage form and serve varied and specialized pharmaceutical functions are known as pharmaceutical ingredients or excipients. • Examples: For solutions- solvents, flavors, sweeteners, colorants, preservatives, stabilizers etc. For tablets- diluents or fillers, binders, lubricants, disintegrating agents etc.
  • 6. What are the purposes of formulating different types of dosage forms? • In order to provide the safe and appropriate dose of a drug to the patient, drug substances are formulated in a dosage forms • Selective use of different excipients produces dosage forms of various types • Besides providing the safe and convenient delivery of accurate dosage, there are different purposes for which different dosage forms are designed. These are : 1) To protect the drug substance from the destructive influences of atmospheric oxygen or humidity (coated tablets, sealed ampuls)
  • 7. Sealed ampoules and coated tablets
  • 8. The purposes … 2) To protect the drug substance from the destructive influences of gastric acid after oral administration ( enteric coated tablets)
  • 9. The purposes … 3) To conceal the bitter, salty or offensive taste or odor of a drug substance (capsules, coated tablets, flavored syrups) 4) To provide liquid preparations of substances that are either insoluble or unstable in the desired vehicle ( suspensions)
  • 10. The purposes … 5) To provide clear liquid dosage forms of substances ( syrups, solution) 6) To provide rate-controlled drug action ( various controlled release tablets, capsules and suspensions) 7) To provide optimal drug action from topical administration sites ( ointments, creams, transdermal patches and ophthalmic ear & nasal preparations)
  • 11. The purposes … 8) To provide for insertion of a drug into one of body’s orifices ( rectal or vaginal suppositories)
  • 12. The purposes … 9) To provide for placement of drugs directly in the bloodstream or body tissues (injections) 10) To provide for optimal drug action through inhalation therapy ( inhalants and inhalation aerosols)
  • 13. Major considerations in dosage form design • Three major things should be considered before designing a dosage form : -The physicochemical considerations - The biochemical considerations - Determination of the desired product type and establishment of a framework for product development
  • 14. Major considerations …. • Then, various initial formulations of the product are developed and examined for desired features (e.g., drug release profile, bioavailability, clinical effectiveness etc.) • The formulation that best meets the goals for the product is selected as “master formula”.
  • 15. Major considerations …. • Then a pilot batch and subsequently large scale production is carried on • Each of the subsequently prepared batch of the product must meet the specifications established in the master formula • Most commonly a manufacturer prepares a drug substance in several dosage forms and strengths for the efficacious and convenient treatment of disease
  • 16. Major considerations…. • Some therapeutic matters are also considered before formulating different kinds of dosage forms like- nature of illness ( whether emergency or not) - manner of treatment ( whether local or systemic action) - the age and anticipated condition of the patient ( for infants and children liquid preparation is preferred, for young patient with cough & vomiting injections or suppositories are preferred)
  • 17. Major considerations…. - in case of swallowing problem, chewable tablet or capsules may be prepared - to reduce the frequency of administration, sustained release or extended released form is preferred - Thus the therapeutic considerations, in turn helps to decide the suitable dosage form, the appropriate route of administration, suitable duration and dose frequency if the drug in question